This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Palandri F, et al. Ruxolitinib discontinuation syndrome: incidence, risk factors, and management in 251 patients with myelofibrosis. Blood Cancer Journal 11: 4, No. 1, Jan 2021. Available from: URL: http://doi.org/10.1038/s41408-020-00392-1